Showing results (171-180 of 486) with videos related to
Sort By:
Pageof 49
Leukemia Research|March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survivalJacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.BMC Gastroenterology|November 27, 2014
Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST)Renate Schmelz, Martin Bornhäuser, Johannes Schetelig, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|March 2, 2026
Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory AnalysisJakob Leonhardi, Tihomir Dermendzhiev, Enrica Bach, et al.Journal of Clinical Epidemiology|March 23, 2021
The EORTC QLU-C10D was more efficient in detecting clinical known group differences in myelodysplastic syndromes than the EQ-5D-3LEva M Gamper, Francesco Cottone, Kathrin Sommer, et al.Leukemia & Lymphoma|October 23, 2002
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantationUwe Platzbecker, Ted Gooley, Claudio Anasetti, et al.Stem Cells (Dayton, Ohio)|September 30, 2015
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term OutcomeFelix von Dalowski, Michael Kramer, Martin Wermke, et al.Blood Advances|August 19, 2018
Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemiaBrian Ball, Rami S Komrokji, Lionel Adès, et al.Blood Advances|March 23, 2022
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AMLSebastian Stasik, Clara Burkhard-Meier, Michael Kramer, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 15, 2012
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidineUwe Platzbecker, Johannes Schetelig, Jürgen Finke, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2018
Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationJan M Middeke, Frederike Kollinger, Henning Baldauf, et al.Pageof 49